Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionJohnson Investment Counsel Inc
Latest Disclosed Ownership14,301 shares
Latest Disclosed Value $ 525,544
Johnson Investment Counsel Inc reports 11.68% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 1, 2026 - Johnson Investment Counsel Inc filed a 13F-HR form disclosing ownership of 14,301 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $451,197 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 16,192 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -11.68% during the quarter. The current value of the position is $512,262 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 14,301 -1,891 -11.68 526 -36.21 0.0042
2026-02-13 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 0 -100.00 0
2026-02-13 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 16,192 824
2025-11-06 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 16,742 -3,637 -17.85 929 -34.00 0.0078
2025-07-25 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 20,379 4,511 28.43 1,407 27.70 0.0126
2025-04-21 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 15,868 -1,739 -9.88 1,102 -27.28 0.0106
2025-02-07 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 17,607 1,617 10.11 1,515 -20.44 0.0148
2024-11-04 2024-09-30 13F NOVO-NORDISK AS ADR AD 670100205 15,990 -2,738 -14.62 1,904 -28.81 0.0187
2024-08-08 2024-06-30 13F NOVO-NORDISK AS ADR AD 670100205 18,728 365 1.99 2,673 13.41 0.0282
2024-05-09 2024-03-31 13F NOVO-NORDISK AS ADR AD 670100205 18,363 -2,739 -12.98 2,358 7.97 0.0256
2024-02-07 2023-12-31 13F NOVO-NORDISK AS ADR AD 670100205 21,102 1,126 5.64 2,183 20.21 0.0256
2023-11-13 2023-09-30 13F NOVO-NORDISK AS AD 670100205 19,976 9,938 99.00 1,817 11.82 0.0234
2023-08-10 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 10,038 -1,279 -11.30 1,624 -9.78 0.0202
2023-05-15 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 11,317 -90 -0.79 1,801 16.66 0.0239
2023-02-14 2022-12-31 13F NOVO-NORDISK A S ADR 670100205 11,407 -2,056 -15.27 1,544 15.06 0.0211
2022-11-14 2022-09-30 13F NOVO-NORDISK AS ADR COM 670100205 13,463 161 1.21 1,341 -9.51 0.0199
2022-08-15 2022-06-30 13F NOVO-NORDISK AS ADR COM 670100205 13,302 -298 -2.19 1,482 -2.76 0.0210
2022-05-11 2022-03-31 13F Novo Nordisk A COMMON EQUITY 670100205 13,600 18 0.13 1,524 0.20 0.0189
2022-02-15 2021-12-31 13F Novo Nordisk A COMMON EQUITY 670100205 13,582 -472 -3.36 1,521 12.75 0.0186
2021-11-12 2021-09-30 13F Novo Nordisk A COMMON EQUITY 670100205 14,054 3,094 28.23 1,349 46.95 0.0181
2021-08-13 2021-06-30 13F Novo Nordisk A COMMON EQUITY 670100205 10,960 -168 -1.51 918 20.63 0.0131
2021-05-14 2021-03-31 13F Novo Nordisk A COMMON EQUITY 670100205 11,128 -100 -0.89 761 -2.93 0.0114
2021-02-12 2020-12-31 13F Novo Nordisk A COMMON EQUITY 670100205 11,228 100 0.90 784 1.42 0.0131
2020-11-16 2020-09-30 13F Novo Nordisk A COMMON EQUITY 670100205 11,128 0 0.00 773 6.04 0.0143
2020-08-13 2020-06-30 13F Novo Nordisk A COMMON EQUITY 670100205 11,128 -1,400 -11.17 729 -4.71 0.0147
2020-05-20 2020-03-31 13F Novo Nordisk A COMMON EQUITY 670100205 12,528 -1,115 -8.17 765 -3.16 0.0169
2020-02-13 2019-12-31 13F Novo Nordisk A COMMON EQUITY 670100205 13,643 0 0.00 790 12.06 0.0149
2019-11-14 2019-09-30 13F Novo Nordisk A COMMON 670100205 13,643 -1,264 -8.48 705 -7.24 0.0140
2019-08-14 2019-06-30 13F NOVO NORDISK A Common 670100205 14,907 2,115 16.53 760 13.60 0.0157
2019-05-13 2019-03-31 13F NOVO NORDISK A Common 670100205 12,792 -915 -6.68 669 6.02 0.0143
2019-02-13 2018-12-31 13F NOVO NORDISK A Common 670100205 13,707 0 0.00 631 -2.32 0.0153
2018-11-14 2018-09-30 13F NOVO NORDISK A Common 670100205 13,707 -72 -0.52 646 1.73 0.0144
2018-08-14 2018-06-30 13F NOVO NORDISK A Common 670100205 13,779 1,330 10.68 635 3.59 0.0156
2018-05-15 2018-03-31 13F NOVO NORDISK A Common 670100205 12,449 -270 -2.12 613 -10.12 0.0157
2018-02-14 2017-12-31 13F NOVO NORDISK A Common 670100205 12,719 112 0.89 682 12.36 0.0170
2017-11-14 2017-09-30 13F NOVO NORDISK A Common 670100205 12,607 -1,092 -7.97 607 3.41 0.0160
2017-08-14 2017-06-30 13F NOVO NORDISK A Common 670100205 13,699 1,561 12.86 587 41.11 0.0163
2017-05-12 2017-03-31 13F NOVO NORDISK A Common 670100205 12,138 -872 -6.70 416 -10.73 0.0120
2017-02-14 2016-12-31 13F NOVO NORDISK A Common 670100205 13,010 1,554 13.56 466 -2.10 0.0143
2016-11-14 2016-09-30 13F NOVO NORDISK A Common 670100205 11,456 -450 -3.78 476 -25.62 0.0152
2016-08-11 2016-06-30 13F NOVO NORDISK A Common 670100205 11,906 450 3.93 640 3.23 0.0211
2016-05-13 2016-03-31 13F NOVO NORDISK A Common 670100205 11,456 -36 -0.31 620 -7.05 0.0217
2016-02-12 2015-12-31 13F NOVO NORDISK A Common 670100205 11,492 -1,379 -10.71 667 -4.44 0.0234
2015-11-16 2015-09-30 13F NOVO NORDISK A Common 670100205 12,871 1,483 13.02 698 12.04 0.0256
2015-08-14 2015-06-30 13F NOVO NORDISK A Common 670100205 11,388 -1,000 -8.07 623 -5.75 0.0209
2015-05-14 2015-03-31 13F NOVO NORDISK A Common 670100205 12,388 245 2.02 661 28.85 0.0222
2015-02-17 2014-12-31 13F NOVO NORDISK A Common 670100205 12,143 243 2.04 513 -9.36 0.0169
2014-11-14 2014-09-30 13F NOVO NORDISK A Common 670100205 11,900 0 0.00 566 3.10 0.0190
2014-08-14 2014-06-30 13F NOVO NORDISK A Common 670100205 11,900 1,005 9.22 549 10.46 0.0196
2014-05-15 2014-03-31 13F NOVO NORDISK A Common 670100205 10,895 8,246 311.29 497 1.64 0.0182
2014-02-13 2013-12-31 13F NOVO NORDISK A Common 670100205 2,649 40 1.53 489 10.88 0.0180
2013-11-13 2013-09-30 13F NOVO NORDISK A Common 670100205 2,609 0 0.00 441 9.16 0.0176
2013-08-14 2013-06-30 13F NOVO NORDISK A Common 670100205 2,609 2,609 404 0.0168
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.